| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.0087 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0081 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |